REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 174 filers reported holding REATA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $180,068,497 | +321.7% | 1,766,070 | +276.1% | 0.39% | +307.3% |
| Q1 2023 | $42,697,669 | -13.9% | 469,618 | -64.0% | 0.10% | -19.3% |
| Q4 2022 | $49,609,355 | +722.4% | 1,305,853 | +444.1% | 0.12% | +693.3% |
| Q3 2022 | $6,032,000 | -80.6% | 240,024 | -76.6% | 0.02% | -78.9% |
| Q2 2022 | $31,150,000 | +1721.6% | 1,025,000 | +5929.4% | 0.07% | +2266.7% |
| Q3 2021 | $1,710,000 | -85.2% | 17,000 | -78.8% | 0.00% | -91.2% |
| Q1 2020 | $11,547,000 | -50.0% | 80,000 | -29.2% | 0.03% | -40.4% |
| Q4 2019 | $23,101,000 | +202.8% | 113,000 | +18.9% | 0.06% | +200.0% |
| Q3 2019 | $7,628,000 | +79.7% | 95,000 | +111.1% | 0.02% | +72.7% |
| Q2 2019 | $4,246,000 | – | 45,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |